9/19議程（上午場）
\r\n
Sep-19-2015
| \r\n
Time (時程) |
\r\n
Topic (題目) |
\r\n
Speaker (演講者) |
\r\n
Institute (單位) |
| \r\n
Sep-19-2015 (Saturday) |
|||
| \r\n
8:30~9:00 |
\r\n
Registration報到 |
||
| \r\n
Session 3: Research on International cooperation strategy 主題3: 國際合作策略探討 |
|||
| \r\n
Moderator: Chieh-Hsi Wu, Professor and Dean 吳介信 院長 |
|||
| \r\n
9:00~9:40 |
\r\n
Anticancer Lead Compound Development from Asian Plants |
\r\n
A. Douglas Kinghorn, Professor |
\r\n
College of Pharmacy, The Ohio State University |
| \r\n
9:40~10:20 |
\r\n
Development of Veregen, a topical ointment with proprietary green tea extract in US and EU |
\r\n
Thorsten Woehl, Ph.D. Vice President CMC |
\r\n
Medigene AG (Planegg/Martinsried, Germany) |
| \r\n
10:20~10:40 |
\r\n
Coffee break 茶敘 |
||
| \r\n
Moderator: Fang-Rong Chang, Professor 張芳榮 教授 |
|||
| \r\n
10:40-11:20 |
\r\n
We are inviting a speaker of Tasly Holding Group to share their experiences with “Compound Danshen Drippping Pills”. |
\r\n
We are inviting a speaker of Tasly Holding Group to share their experiences with “Compound Danshen Drippping Pills”. |
\r\n
Tasly Holding Group 天士力控股集團 |
| \r\n
11:20-12:00 |
\r\n
International Cooperation Strategy and Developmental Trends of Traditional Chinese Medicine 中醫藥國際合作策略與發展趨勢分析 |
\r\n
Tsu-Hwie Annie Liu, Ph.D. 劉祖惠博士 |
\r\n
Development Center for Biotechnology 財團法人生物技術開發中心 |
| \r\n
12:00~13:30 |
\r\n
Lunch 午餐 |
